Marvell Technology, Inc. Total Cost of Revenue increased by 6.6% to $1.07B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 142.3%, from $442.00M to $1.07B. Over 4 years (FY 2022 to FY 2026), Total Cost of Revenue shows an upward trend with a 19.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $414.10M | $704.10M | $623.40M | $211.30M | $696.00M | $730.90M | $760.00M | $480.40M | $764.50M | $819.80M | $867.40M | $729.00M | $633.10M | $685.30M | $1.17B | $442.00M | $942.90M | $995.50M | $1.00B | $1.07B |
| QoQ Change | — | +70.0% | -11.5% | -66.1% | +229.4% | +5.0% | +4.0% | -36.8% | +59.1% | +7.2% | +5.8% | -16.0% | -13.2% | +8.2% | +70.2% | -62.1% | +113.3% | +5.6% | +0.9% | +6.6% |
| YoY Change | — | — | — | — | +68.1% | +3.8% | +21.9% | +127.4% | +9.8% | +12.2% | +14.1% | +51.7% | -17.2% | -16.4% | +34.5% | -39.4% | +48.9% | +45.3% | -13.9% | +142.3% |